Institutional funds have multi-million dollar quant research desks to protect their wealth. We democratize that exact institutional precision for individual and HNI equity investors across India.
Founded by veteran equity research analysts and algorithmic systems architects, Realexus Capital solves a critical vulnerability: over 85% of Indian retail portfolios bleed silently because investors hold onto loss-making stocks out of hope, while selling winning compounders too early.
By combining instant machine-learning diagnostics with human analyst oversight, we help investors prune weak holdings, manage downside risk, and redeploy capital into high-conviction compounders.
Proprietary algorithms scanning 50+ technical indicators, momentum breaks, and valuation ratios 24/7 without fatigue or emotion.
Seasoned Dalal Street research analysts who evaluate corporate governance, quarterly earnings quality, and macro tailwinds.
Actionable Buy, Hold, or Review verdicts with targeted stop-losses and clear profit horizons.
Rule #1 of compounding is never to lose large chunks of capital. We detect deteriorating fundamentals before major stock crashes happen.
We never accept broker rebates or distribute questionable IPOs. Our research recommendations are 100% aligned with client wealth generation.
We focus client capital into 12–15 high-conviction companies with superior Return on Equity (>18%) and clear industry leadership.
